Hematopoiesis from Human Embryonic Stem Cells: Overcoming the Immune Barrier in - 《stemcells》干细胞学杂志干细胞之家



免疫细胞治疗专区	欢迎关注干细胞微信公众号

12 3 4 5 6 7 8 9 10 ... 25 下一页

返回列表

查看: 410481\|回复: 244	go Hematopoiesis from Human Embryonic Stem Cells: Overcoming the Immune Barrier in [复制链接]

江边孤钓

版主

Rank: 7 Rank: 7 Rank: 7

积分: 0
威望: 0
包包: 483

楼主

发表于 2009-3-5 00:08 |只看该作者 |倒序浏览 |打印

作者：Helen Priddlea,b, D. Rhodri E. Jonesc, Paul W. Burridgea,b,c, Roger Patientb作者单位：a Department of Obstetrics and Gynaecology, School of Human Development,
   7 I, ?' _8 @3 |# T
   ' c- h. E* C/ M( X; b! S
      2 C1 n) ~9 Y' F& Q. L$ }6 E! T
                     ' e+ ?) b/ x" D7 \0 x
         & x  O4 Q. X, g# ], L
         : a3 H7 C6 X* \2 ?) o% M' i
         - C# [" v- p, e* r( w$ ?


      - [1 [* L! r' ~4 g# Q; P- h


      【摘要】
   The multipotency and proliferative capacity of human embryonic stem cells (hESCs) make them a promising source of stem cells for transplant therapies and of vital importance given the shortage in organ donation. Recent studies suggest some immune privilege associated with hESC-derived tissues. However, the adaptability of the immune system makes it unlikely that fully differentiated tissues will permanently evade immune rejection. One promising solution is to induce a state of immune tolerance to a hESC line using tolerogenic hematopoietic cells derived from it. This could provide acceptance of other differentiated tissues from the same line. However, this approach will require efficient multilineage hematopoiesis from hESCs. This review proposes that more efficient differentiation of hESCs to the tolerogenic cell types required is most likely to occur through applying knowledge gained of the ontogeny of complex regulatory signals used by the embryo for definitive hematopoietic development in vivo. Stepwise formation of mesoderm, induction of definitive hematopoietic stem cells, and the application of factors key to their self-renewal may improve in vitro production both quantitatively and qualitatively.
      【关键词】 Development Immune tolerance Stem cell therapies Human embryonic stem cells Hematopoiesis Differentiation5 t+ ^: ?8 S+ x: d: [% c

      【参考文献】
* The article cited in reference 17 has been retracted by Science.

REFERENCES( X6 x+ m0 X5 X8 i5 m! s! ]7 Y; t

Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145¨C1147." C4 @5 A- s) P5 @! [# X
3 {3 G& d$ e" V. M# e; O
Amit M, Carpenter MK, Inokuma MS et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000;227:271¨C278.

Bradley JA, Bolton EM, Pedersen RA. Stem cell medicine encounters the immune system. Nat Rev Immunol 2002;2:859¨C871.

Martin M, Schwinzer R, Schellekens H et al. Glomerular mesangial cells in local inflammation. Induction of the expression of MHC class II antigens by IFN-gamma. J Immunol 1989;142:1887¨C1894.

Jiang S, Herrera O, Lechler RI. New spectrum of allorecognition pathways: Implications for graft rejection and transplantation tolerance. Curr Opin Immunol 2004;16:550¨C557.

Drukker M, Katz G, Urbach A et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 2002;99:9864¨C9869.3 h! _5 G* ^, g! _  c

Li L, Baroja ML, Majumdar A et al. Human embryonic stem cells possess immune-privileged properties. STEM CELLS 2004;22:448¨C456.
8 r, Q2 _' @" @4 u
Fandrich F, Lin X, Chai GX et al. Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 2002;8:171¨C178.

Ginis I, Luo Y, Miura T et al. Differences between human and mouse embryonic stem cells. Dev Biol 2004;269:360¨C380.. D( q- A+ Q" Q+ T- N0 |

Fandrich F, Dresske B, Bader M et al. Embryonic stem cells share immune-privileged features relevant for tolerance induction. J Mol Med 2002;80:343¨C350.
9 O3 g9 n3 A9 L" ^- b5 j
Mummery C, Ward-Van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 2003; 107:2733¨C2740.
8 j$ E* W! p7 c" C5 p
Segev H, Fishman B, Ziskind A et al. Differentiation of human embryonic stem cells into insulin-producing clusters. STEM CELLS 2004;22: 265¨C274.

Lu SJ, Li F, Vida L et al. CD34 CD38¨C hematopoietic precursors derived from human embryonic stem cells exhibit an embryonic gene expression pattern. Blood 2004;103:4134¨C4141.

Zhan X, Dravid G, Ye Z et al. Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. Lancet 2004;364: 163¨C171.! \2 h& k6 G+ Q, T( _

D¡¯Orazio TJ, Niederkorn JY. A novel role for TGF-beta and IL-10 in the induction of immune privilege. J Immunol 1998;160:2089¨C2098.) P8 s4 H2 H! F( C

Kwidzinski E, Bunse J, Aktas O et al. Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. Faseb J 2005;19:1347¨C1349.

*Hwang WS, Roh SI, Lee BC et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science 2005;308:1777¨C1783.
- L6 P  q5 U5 w! l  g9 W# b
Lanza RP, Chung HY, Yoo JJ et al. Generation of histocompatible tissues using nuclear transplantation. Nat Biotechnol 2002;20:689¨C696.9 U5 G+ [0 V& [' O% W% t  w
# I! {0 t9 P' ]
Allegrucci C, Denning C, Priddle H et al. Stem-cell consequences of embryo epigenetic defects. Lancet 2004;364:206¨C208.
/ [3 |) y5 B: o8 d2 d" n( L. o) O
Pincock S. UK opens embryonic stem cell bank. Lancet 2004;363:1778., y7 D& p1 K4 |  u) s4 c% ?, E1 j
& e& r0 j* z+ H4 P2 g* _9 t
Faden RR, Dawson L, Bateman-House AS et al. Public stem cell banks: Considerations of justice in stem cell research and therapy. Hastings Center Report 2003;33:13¨C27., |$ i0 n. S* X! p6 [) t
) P  c  x3 Y: z. `* d$ C% q
Priddle H. Transfection of human ES cells. In: McWhir J, Thomson A, eds. Gene Targeting and Embryonic Stem Cells. Abingdon, U.K.: BIOS Scientific Publishers Ltd., 2003., z4 o6 w' u! I4 h
  @# c  _$ W+ q+ y" d& w, _  S6 u7 D
Denning C, Priddle H. New frontiers in gene targeting and cloning: Success, application and challenges in domestic animals and human embryonic stem cells. Reproduction 2003;126:1¨C11.
: g9 E% c1 A4 M; l
Tse WT, Pendleton JD, Beyer WM et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 2003;75:389¨C397.
2 v1 Z% l; S; u! W, ]6 U* Y
Fairchild PJ, Cartland S, Nolan KF et al. Embryonic stem cells and the challenge of transplantation tolerance. Trends Immunol 2004;25:465¨C470.
  O8 R+ E+ R5 }! ~% P  Y% O9 e
Reisner Y, Gur H, Reich-Zeliger S et al. Hematopoietic stem cell transplantation across major genetic barriers: Tolerance induction by megadose CD34 cells and other veto cells. In: Orlic D, Brummendorf TH, Fibbe W et al., eds. Hematopoietic Stem Cells 2002: Genetics and Function ¨C Fourth International Symposium. Vol. 996: New York: New York Academy of Sciences, 2003:72¨C79.+ v" G. a2 x- A
! d8 c: s- q6 m! G
Hosoi T, Yahara S, Kunitomo K et al. Blood chimeric twins: An example of blood cell chimerism. Vox Sang 1977;32:339¨C341.

van Dijk BA, Boomsma DI, de Man AJ. Blood group chimerism in human multiple births is not rare. Am J Med Genet 1996;61:264¨C268.' Q: T: ^4 C: [  z8 f( D

Vietor HE, Hamel BC, van Bree SP et al. Immunological tolerance in an HLA non-identical chimeric twin. Hum Immunol 2000;61:190¨C192.

Reisner Y, Kapoor N, Kirkpatrick D et al. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983;61:341¨C348.# K1 y% t2 D1 ~! r2 m

Aversa F, Tabilio A, Terenzi A et al. Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994;84:3948¨C3955.
4 K9 @; r0 c* }+ `4 C3 B
Barber WH, Mankin JA, Laskow DA et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51:70¨C75.7 S7 D+ J0 e3 I$ L4 _# l! j

Millan MT, Shizuru JA, Hoffmann P et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 2002; 73:1386¨C1391.2 N' Z1 s- m" N) A! K7 [) z

Reisner Y, Martelli MF. Transplantation tolerance induced by "mega dose" CD34  cell transplants. Exp Hematol 2000;28:119¨C127.8 Z. z& `$ B% ~/ b. O
' N9 ^& a& s2 |$ E5 c* d' @7 s
Hale DA, Gottschalk R, Umemura A et al. Establishment of stable multilineage hematopoietic chimerism and donor-specific tolerance without irradiation. Transplantation 2000;69:1242¨C1251.( D  \* S/ P( f4 c9 K. c
: ]( W2 x- g& t2 {
Umemura A, Monaco AP, Maki T. Donor MHC class II antigen is essential for induction of transplantation tolerance by bone marrow cells. J Immunol 2000;164:4452¨C4457.
7 Q5 [$ g" ]  Q0 P8 \
Sykes M, Szot GL, Swenson KA et al. Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning. Nat Med 1997;3:783¨C787.5 e) \3 O$ o) r9 X
* e. g; J% h6 [1 V4 o
Xu H, Chilton PM, Huang Y et al. Production of donor T cells is critical for induction of donor-specific tolerance and maintenance of chimerism. J Immunol 2004;172:1463¨C1471.
; q' ~3 a+ H) ~& z& _6 t$ x
Shizuru JA, Weissman IL, Kernoff R et al. Purified hematopoietic stem cell grafts induce tolerance to alloantigens and can mediate positive and negative T cell selection. Proc Natl Acad Sci U S A 2000;97:9555¨C9560.. m" `" L0 h' f' E: L; W( a
9 p5 J% y1 P+ y% m6 @
Gur H, Krauthgamer R, Berrebi A et al. Tolerance induction by mega-dose hematopoietic progenitor cells: Expansion of veto cells by short-term culture of purified human CD34( ) cells. Blood 2002;99:4174¨C4181.4 w/ X! C, w8 k4 m% S
; U, N, ^" i1 s8 x, F4 z
Shirwan H, Wang HK, Barwari L et al. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism. Transplantation 1996;61:1382¨C1386.

Lechler RI, Garden OA, Turka LA. The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 2003;3:147¨C158.; W1 N* y8 T, k& {( e& X

Fehr T, Sykes M. Tolerance induction in clinical transplantation. Transpl Immunol 2004;13:117¨C130.( h5 s+ z% z6 U: G  \7 |
. N+ }2 ?+ ^9 B6 ^! A4 H
Burt RK, Verda L, Kim DA et al. Embryonic stem cells as an alternate marrow donor source: Engraftment without graft-versus-host disease. J Exp Med 2004;199:895¨C904.
  I: i5 ~7 G3 H% s( \2 q
Gerecht-Nir S, Itskovitz-Eldor J. Cell therapy using human embryonic stem cells. Transpl Immunol 2004;12:203¨C209.8 b# q1 u1 C% t! ^

Kaufman DS, Hanson ET, Lewis RL et al. Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A 2001;98:10716¨C10721.! u- J& F/ F+ D, i/ q2 G

Chadwick K, Wang L, Li L et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003;102:906¨C915.- g) K7 q  H! e; f

Perrier AL, Tabar V, Barberi T et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A 2004;101:12543¨C12548.

Tavian M, Robin C, Coulombel L et al. The human embryo, but not its yolk sac, generates lympho-myeloid stem cells: Mapping multipotent hematopoietic cell fate in intraembryonic mesoderm. Immunity 2001; 15:487¨C495.6 ~8 w/ O% D. \8 i

Joubin K, Stern CD. Formation and maintenance of the organizer among the vertebrates. Int J Dev Biol 2001;45:165¨C175.
/ k# X: L/ c1 S% T# A
Calhoun JD, Rao RR, Warrenfeltz S et al. Transcriptional profiling of initial differentiation events in human embryonic stem cells. Biochem Biophys Res Commun 2004;323:453¨C464.% e, a$ b$ ]! D4 V5 b
! U2 {5 s2 f0 \* k( Q4 {
Kimelman D, Griffin KJ. Vertebrate mesendoderm induction and patterning. Curr Opin Genet Dev 2000;10:350¨C356.
  W3 |) Y3 s) l( `
Rodaway A, Patient R. Mesendoderm. An ancient germ layer? Cell 2001;105:169¨C172.
1 b6 f# o) X* M
Loose M, Patient R. A genetic regulatory network for Xenopus mesendoderm formation. Dev Biol 2004;271:467¨C478.( v# ]" Q- c" M1 b. ?

Latinkic BV, Umbhauer M, Neal KA et al. The Xenopus Brachyury promoter is activated by FGF and low concentrations of activin and suppressed by high concentrations of activin and by paired-type homeodomain proteins. Genes Dev 1997;11:3265¨C3276.

Vonica A, Gumbiner BM. Zygotic Wnt activity is required for Brachyury expression in the early Xenopus laevis embryo. Dev Biol 2002;250:112¨C127.6 v) j# h2 [4 w. _
7 Q) |/ b+ \+ x' k
Northrop J, Woods A, Seger R et al. BMP-4 regulates the dorsal-ventral differences in FGF/MAPKK-mediated mesoderm induction in Xenopus. Dev Biol 1995;172:242¨C252.- s: d* e4 Y1 q/ ]5 q/ u  |2 Q
2 R4 A# ?5 B' T6 p4 g: p
Artinger M, Blitz I, Inoue K et al. Interaction of goosecoid and brachyury in Xenopus mesoderm patterning. Mech Dev 1997;65:187¨C196.* R( l* c; n5 f& K* [, v" A( q

Boucher DM, Schaffer M, Deissler K et al. goosecoid expression represses Brachyury in embryonic stem cells and affects craniofacial development in chimeric mice. Int J Dev Biol 2000;44:279¨C288.7 @7 S( w  [1 l+ p) f, H( G
9 I) p' J  Z& [* l& g& I- K1 A
Latinkic BV, Smith JC. Goosecoid and mix. 1 repress Brachyury expression and are required for head formation in Xenopus. Development 1999;126:1769¨C1779.6 l4 z" c# x4 N3 W' ^( a6 |
- k. J* R0 [" F4 n+ b% l2 p
Kubo A, Shinozaki K, Shannon JM et al. Development of definitive endoderm from embryonic stem cells in culture. Development 2004; 131:1651¨C1662.
9 Y# G0 J5 r9 \5 _0 u: t* J2 Q/ s
Kau CL, Turpen JB. Dual contribution of embryonic ventral blood island and dorsal lateral plate mesoderm during ontogeny of hemopoietic cells in Xenopus laevis. J Immunol 1983;131:2262¨C2266.. P7 U( B: _) \4 D3 m/ C

Wilson V, Beddington RS. Cell fate and morphogenetic movement in the late mouse primitive streak. Mech Dev 1996;55:79¨C89.
: v. s+ R0 ], s; T+ o. R) V. i
Smith JL, Gesteland KM, Schoenwolf GC. Prospective fate map of the mouse primitive streak at 7.5 days of gestation. Dev Dyn 1994;201: 279¨C289./ P2 i4 o# t* b  w
+ t9 ^2 j$ W+ F, g* B5 B; v3 b! h
Sawada K, Aoyama H. Fate maps of the primitive streak in chick and quail embryo: Ingression timing of progenitor cells of each rostro-caudal axial level of somites. Int J Dev Biol 1999;43:809¨C815.$ d6 p' H" |' h

Lu CC, Robertson EJ. Multiple roles for Nodal in the epiblast of the mouse embryo in the establishment of anterior-posterior patterning. Dev Biol 2004;273:149¨C159.
2 n, |5 `* g( m- b
Winnier G, Blessing M, Labosky PA et al. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995;9:2105¨C2116.

Eimon PM, Harland RM. In Xenopus embryos, BMP heterodimers are not required for mesoderm induction, but BMP activity is necessary for dorsal/ventral patterning. Dev Biol 1999;216:29¨C40.

Li F, Lu S, Vida L et al. Bone morphogenetic protein 4 induces efficient hematopoietic differentiation of rhesus monkey embryonic stem cells in vitro. Blood 2001;98:335¨C342.
. o  e* k  I  U+ N; S3 u; M
Hoppler S, Moon RT. BMP-2/-4 and Wnt-8 cooperatively pattern the Xenopus mesoderm. Mech Dev 1998;71:119¨C129.
' X# a5 ]) p& g
Neave B, Holder N, Patient R. A graded response to BMP-4 spatially coordinates patterning of the mesoderm and ectoderm in the zebrafish. Mech Dev 1997;62:183¨C195.# g# J& s" w! q5 y4 i4 I" B" B
& h$ s1 d8 W( ?% j  `) Z. H( m
Okabayashi K, Asashima M. Tissue generation from amphibian animal caps. Curr Opin Genet Dev 2003;13:502¨C507.

Fehling HJ, Lacaud G, Kubo A et al. Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development 2003;130:4217¨C4227.7 Y" W; r8 u" s8 z* j
! R: |/ n2 V7 J  `
Cortes F, Debacker C, Peault B et al. Differential expression of KDR/VEGFR-2 and CD34 during mesoderm development of the early human embryo. Mech Dev 1999;83:161¨C164./ Q7 d* z( j+ {) Z
8 e3 f/ ]6 W1 V1 z) C) }" ^
Choi K, Kennedy M, Kazarov A et al. A common precursor for hematopoietic and endothelial cells. Development 1998;125:725¨C732.5 K2 y! U9 E0 V8 P) C( w# w: y
+ e7 W$ L1 Y6 l6 {0 q
Hamaguchi I, Huang XL, Takakura N et al. In vitro hematopoietic and endothelial cell development from cells expressing TEK receptor in murine aorta-gonad-mesonephros region. Blood 1999;93:1549¨C1556.

Bailey AS, Jiang S, Afentoulis M et al. Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood 2004;103:13¨C19.
/ H$ r$ C+ d, e2 A
Pelosi E, Valtieri M, Coppola S et al. Identification of the hemangioblast in postnatal life. Blood 2002;100:3203¨C3208.+ t4 E8 d9 t% k2 w
" V8 H, ~' j( H( s9 v! L
Wang L, Li L, Shojaei F et al. Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 2004;21:31¨C41.
; j& `* U2 E! Y  c$ }8 x  W# f% a
Ema M, Faloon P, Zhang WJ et al. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse. Genes Dev 2003;17:380¨C393.* f: l, [! ?' p, g! c  O

Kabrun N, Buhring HJ, Choi K et al. Flk-1 expression defines a population of early embryonic hematopoietic precursors. Development 1997;124:2039¨C2048.

Park C, Afrikanova I, Chung YS et al. A hierarchical order of factors in the generation of FLK1- and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development 2004;131: 2749¨C2762.

Patterson LJ, Gering M, Patient R. Scl is required for dorsal aorta as well as blood formation in zebrafish embryos. Blood 2005;105:3502¨C3511.! P8 a! T+ q; v" y  L
- G. W+ ?7 N% d: Z
Gering M, Patient R. Hedgehog signalling is required for adult blood stem cell formation in zebrafish embryos. Dev Cell 2005;8:389¨C400.8 t: ^* k1 f5 Z# H  r; g/ G4 a
( Q9 K' ?2 [6 i3 a9 p/ T9 }
Gering M, Rodaway AR, Gottgens B et al. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J 1998;17: 4029¨C4045.! }4 K/ y  R( `+ \+ o& ?$ }

Gering M, Yamada Y, Rabbitts TH et al. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Development 2003;130:6187¨C6199.

Elefanty AG, Robb L, Birner R et al. Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. Blood 1997;90:1435¨C1447.% n/ a; o$ P1 i
1 z* o) y$ f2 X6 W9 i
Schlaeger TM, Mikkola HK, Gekas C et al. Tie2Cre mediated gene ablation defines the Stem Cell Le

收藏0 分享0 顶0 踩0